mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |